Skip to main content
Caplight Logo









Terray Therapeutics

Terray Therapeutics

Private
Monrovia, CaliforniaHealthcare & Life Scienceshttps://www.terraytx.com/

Last Round

Series B

Oct 17, 2024

Est. Valuation

$600M

Total Funding Raised

$220M

Momentum

Top 50%

of companies Caplight tracks

Company Overview

Terray Therapeutics is a biotechnology company that delivers precise chemical datasets to enhance drug discovery through the integration of artificial intelligence, synthetic chemistry, automation, and nanotechnology.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology, Medical AI, ML Platforms

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Application

Keywords

drug discoverysmall molecule discoveryAI drug discoveryde novo drug designin silico drug discoverypredictive modelingbiotech AIhigh-throughput screeningchemical space explorationpharma partnershipmilestone-based paymentsAI-native platformcomputational chemistrydrug development pipelinetechbio

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Terray Therapeutics Comparables

Compare Terray Therapeutics with similar companies based on industry and business-model similarity.

Terray Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Genesis Therapeutics
87%
Iambic Therapeutics
86%
Recursion Pharmaceuticals
84%

Terray Therapeutics Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series BOct 17, 2024
Series AFeb 15, 2022
SeedJun 30, 2021

Key People

Founding team and executive leadership

Narbe Mardirossian

Chief Technology Officer

Executive Team

Terray Therapeutics Investors

Notable investors and investment history

Terray Therapeutics investors
InvestorRounds
Maverick CapitalSeries B
Digitalis VenturesSeed, Series A, Series B
Maverick CapitalSeries B
Greentrail PartnersSeries A
XTX MarketsSeries A
Two Sigma VenturesSeries B, Series A, Seed
Alexandria Venture InvestmentsSeries B, Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 16, 2026

    Monthly visitors grew 41% MoM, reaching 33.2K.

  • Nov 17, 2025

    Launched an experiment-driven ML platform for small-molecule discovery.

Terray Therapeutics Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Terray Therapeutics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Terray Therapeutics's valuation, stock price, and market status.

Firmographic Details

HeadquartersMonrovia, California
Employee Range143
Year Founded2018
Last FundingOct 17, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?